Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
GCC Countries Radiopharmaceutical market report explains the definition, types, applications, major countries, and major players of the GCC Countries Radiopharmaceutical market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Dongcheng
Advanced Accelerator Applications
SIEMENS
Bayer
Eli Lilly
Mallinckrodt
Bracco Imaging
Triad Isotopes
Nordion
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
IBA Group
Lantheus
Navidea
By Type:
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
By End-User:
Oncology
Cardiology
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global GCC Countries Radiopharmaceutical Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 GCC Countries Radiopharmaceutical Outlook to 2028- Original Forecasts
-
2.2 GCC Countries Radiopharmaceutical Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term GCC Countries Radiopharmaceutical Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global GCC Countries Radiopharmaceutical Market- Recent Developments
-
6.1 GCC Countries Radiopharmaceutical Market News and Developments
-
6.2 GCC Countries Radiopharmaceutical Market Deals Landscape
7 GCC Countries Radiopharmaceutical Raw Materials and Cost Structure Analysis
-
7.1 GCC Countries Radiopharmaceutical Key Raw Materials
-
7.2 GCC Countries Radiopharmaceutical Price Trend of Key Raw Materials
-
7.3 GCC Countries Radiopharmaceutical Key Suppliers of Raw Materials
-
7.4 GCC Countries Radiopharmaceutical Market Concentration Rate of Raw Materials
-
7.5 GCC Countries Radiopharmaceutical Cost Structure Analysis
-
7.5.1 GCC Countries Radiopharmaceutical Raw Materials Analysis
-
7.5.2 GCC Countries Radiopharmaceutical Labor Cost Analysis
-
7.5.3 GCC Countries Radiopharmaceutical Manufacturing Expenses Analysis
8 Global GCC Countries Radiopharmaceutical Import and Export Analysis (Top 10 Countries)
-
8.1 Global GCC Countries Radiopharmaceutical Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global GCC Countries Radiopharmaceutical Export by Region (Top 10 Countries) (2017-2028)
9 Global GCC Countries Radiopharmaceutical Market Outlook by Types and Applications to 2022
-
9.1 Global GCC Countries Radiopharmaceutical Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Actinium-225 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Lutetium-177 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Radium-223 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Holmium-166 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global GCC Countries Radiopharmaceutical Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cardiology Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise GCC Countries Radiopharmaceutical Market Analysis and Outlook till 2022
-
10.1 Global GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.2.2 Canada GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.2.3 Mexico GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.3.2 UK GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.3.3 Spain GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.3.4 Belgium GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.3.5 France GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.3.6 Italy GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.3.7 Denmark GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.3.8 Finland GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.3.9 Norway GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.3.10 Sweden GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.3.11 Poland GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.3.12 Russia GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.3.13 Turkey GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.4.2 Japan GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.4.3 India GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.4.4 South Korea GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.4.5 Pakistan GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.4.6 Bangladesh GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.4.7 Indonesia GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.4.8 Thailand GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.4.9 Singapore GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.4.10 Malaysia GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.4.11 Philippines GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.4.12 Vietnam GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.5.2 Colombia GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.5.3 Chile GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.5.4 Argentina GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.5.5 Venezuela GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.5.6 Peru GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.5.7 Puerto Rico GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.5.8 Ecuador GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.6.2 Kuwait GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.6.3 Oman GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.6.4 Qatar GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.6.5 Saudi Arabia GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.6.6 United Arab Emirates GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.7.2 South Africa GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.7.3 Egypt GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.7.4 Algeria GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia GCC Countries Radiopharmaceutical Consumption (2017-2022)
-
10.8.2 New Zealand GCC Countries Radiopharmaceutical Consumption (2017-2022)
11 Global GCC Countries Radiopharmaceutical Competitive Analysis
-
11.1 Dongcheng
-
11.1.1 Dongcheng Company Details
-
11.1.2 Dongcheng GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Dongcheng GCC Countries Radiopharmaceutical Main Business and Markets Served
-
11.1.4 Dongcheng GCC Countries Radiopharmaceutical Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Advanced Accelerator Applications
-
11.2.1 Advanced Accelerator Applications Company Details
-
11.2.2 Advanced Accelerator Applications GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Advanced Accelerator Applications GCC Countries Radiopharmaceutical Main Business and Markets Served
-
11.2.4 Advanced Accelerator Applications GCC Countries Radiopharmaceutical Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 SIEMENS
-
11.3.1 SIEMENS Company Details
-
11.3.2 SIEMENS GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 SIEMENS GCC Countries Radiopharmaceutical Main Business and Markets Served
-
11.3.4 SIEMENS GCC Countries Radiopharmaceutical Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Bayer
-
11.4.1 Bayer Company Details
-
11.4.2 Bayer GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Bayer GCC Countries Radiopharmaceutical Main Business and Markets Served
-
11.4.4 Bayer GCC Countries Radiopharmaceutical Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Eli Lilly
-
11.5.1 Eli Lilly Company Details
-
11.5.2 Eli Lilly GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Eli Lilly GCC Countries Radiopharmaceutical Main Business and Markets Served
-
11.5.4 Eli Lilly GCC Countries Radiopharmaceutical Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Mallinckrodt
-
11.6.1 Mallinckrodt Company Details
-
11.6.2 Mallinckrodt GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Mallinckrodt GCC Countries Radiopharmaceutical Main Business and Markets Served
-
11.6.4 Mallinckrodt GCC Countries Radiopharmaceutical Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Bracco Imaging
-
11.7.1 Bracco Imaging Company Details
-
11.7.2 Bracco Imaging GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Bracco Imaging GCC Countries Radiopharmaceutical Main Business and Markets Served
-
11.7.4 Bracco Imaging GCC Countries Radiopharmaceutical Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Triad Isotopes
-
11.8.1 Triad Isotopes Company Details
-
11.8.2 Triad Isotopes GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Triad Isotopes GCC Countries Radiopharmaceutical Main Business and Markets Served
-
11.8.4 Triad Isotopes GCC Countries Radiopharmaceutical Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Nordion
-
11.9.1 Nordion Company Details
-
11.9.2 Nordion GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Nordion GCC Countries Radiopharmaceutical Main Business and Markets Served
-
11.9.4 Nordion GCC Countries Radiopharmaceutical Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 GE Healthcare
-
11.10.1 GE Healthcare Company Details
-
11.10.2 GE Healthcare GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 GE Healthcare GCC Countries Radiopharmaceutical Main Business and Markets Served
-
11.10.4 GE Healthcare GCC Countries Radiopharmaceutical Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 China Isotope & Radiation
-
11.11.1 China Isotope & Radiation Company Details
-
11.11.2 China Isotope & Radiation GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 China Isotope & Radiation GCC Countries Radiopharmaceutical Main Business and Markets Served
-
11.11.4 China Isotope & Radiation GCC Countries Radiopharmaceutical Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Jubilant Pharma
-
11.12.1 Jubilant Pharma Company Details
-
11.12.2 Jubilant Pharma GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Jubilant Pharma GCC Countries Radiopharmaceutical Main Business and Markets Served
-
11.12.4 Jubilant Pharma GCC Countries Radiopharmaceutical Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 IBA Group
-
11.13.1 IBA Group Company Details
-
11.13.2 IBA Group GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 IBA Group GCC Countries Radiopharmaceutical Main Business and Markets Served
-
11.13.4 IBA Group GCC Countries Radiopharmaceutical Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Lantheus
-
11.14.1 Lantheus Company Details
-
11.14.2 Lantheus GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Lantheus GCC Countries Radiopharmaceutical Main Business and Markets Served
-
11.14.4 Lantheus GCC Countries Radiopharmaceutical Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Navidea
-
11.15.1 Navidea Company Details
-
11.15.2 Navidea GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Navidea GCC Countries Radiopharmaceutical Main Business and Markets Served
-
11.15.4 Navidea GCC Countries Radiopharmaceutical Product Portfolio
-
11.15.5 Recent Research and Development Strategies
12 Global GCC Countries Radiopharmaceutical Market Outlook by Types and Applications to 2028
-
12.1 Global GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Actinium-225 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Lutetium-177 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Radium-223 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Holmium-166 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Cardiology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise GCC Countries Radiopharmaceutical Market Analysis and Outlook to 2028
-
13.1 Global GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.2.2 Canada GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.2.3 Mexico GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.3.2 UK GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.3.3 Spain GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.3.4 Belgium GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.3.5 France GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.3.6 Italy GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.3.7 Denmark GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.3.8 Finland GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.3.9 Norway GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.3.10 Sweden GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.3.11 Poland GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.3.12 Russia GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.3.13 Turkey GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.4.2 Japan GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.4.3 India GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.4.4 South Korea GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.4.5 Pakistan GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.4.7 Indonesia GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.4.8 Thailand GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.4.9 Singapore GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.4.10 Malaysia GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.4.11 Philippines GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.4.12 Vietnam GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.5.2 Colombia GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.5.3 Chile GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.5.4 Argentina GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.5.5 Venezuela GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.5.6 Peru GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.5.8 Ecuador GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.6.2 Kuwait GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.6.3 Oman GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.6.4 Qatar GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.7.2 South Africa GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.7.3 Egypt GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.7.4 Algeria GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
-
13.8.2 New Zealand GCC Countries Radiopharmaceutical Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of GCC Countries Radiopharmaceutical
-
Figure of GCC Countries Radiopharmaceutical Picture
-
Table Global GCC Countries Radiopharmaceutical Import by Region (Top 10 Countries) (2017-2028)
-
Table Global GCC Countries Radiopharmaceutical Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Actinium-225 Consumption and Growth Rate (2017-2022)
-
Figure Global Lutetium-177 Consumption and Growth Rate (2017-2022)
-
Figure Global Radium-223 Consumption and Growth Rate (2017-2022)
-
Figure Global Holmium-166 Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiology Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global GCC Countries Radiopharmaceutical Consumption by Country (2017-2022)
-
Table North America GCC Countries Radiopharmaceutical Consumption by Country (2017-2022)
-
Figure United States GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Canada GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Mexico GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Table Europe GCC Countries Radiopharmaceutical Consumption by Country (2017-2022)
-
Figure Germany GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure UK GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Spain GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Belgium GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure France GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Italy GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Denmark GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Finland GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Norway GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Sweden GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Poland GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Russia GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Turkey GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Table APAC GCC Countries Radiopharmaceutical Consumption by Country (2017-2022)
-
Figure China GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Japan GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure India GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure South Korea GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Pakistan GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Indonesia GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Thailand GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Singapore GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Malaysia GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Philippines GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Vietnam GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Table South America GCC Countries Radiopharmaceutical Consumption by Country (2017-2022)
-
Figure Brazil GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Colombia GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Chile GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Argentina GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Venezuela GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Peru GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Ecuador GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Table GCC GCC Countries Radiopharmaceutical Consumption by Country (2017-2022)
-
Figure Bahrain GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Kuwait GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Oman GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Qatar GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Table Africa GCC Countries Radiopharmaceutical Consumption by Country (2017-2022)
-
Figure Nigeria GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure South Africa GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Egypt GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Algeria GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Table Oceania GCC Countries Radiopharmaceutical Consumption by Country (2017-2022)
-
Figure Australia GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure New Zealand GCC Countries Radiopharmaceutical Consumption and Growth Rate (2017-2022)
-
Table Dongcheng Company Details
-
Table Dongcheng GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dongcheng GCC Countries Radiopharmaceutical Main Business and Markets Served
-
Table Dongcheng GCC Countries Radiopharmaceutical Product Portfolio
-
Table Advanced Accelerator Applications Company Details
-
Table Advanced Accelerator Applications GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Advanced Accelerator Applications GCC Countries Radiopharmaceutical Main Business and Markets Served
-
Table Advanced Accelerator Applications GCC Countries Radiopharmaceutical Product Portfolio
-
Table SIEMENS Company Details
-
Table SIEMENS GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table SIEMENS GCC Countries Radiopharmaceutical Main Business and Markets Served
-
Table SIEMENS GCC Countries Radiopharmaceutical Product Portfolio
-
Table Bayer Company Details
-
Table Bayer GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer GCC Countries Radiopharmaceutical Main Business and Markets Served
-
Table Bayer GCC Countries Radiopharmaceutical Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly GCC Countries Radiopharmaceutical Main Business and Markets Served
-
Table Eli Lilly GCC Countries Radiopharmaceutical Product Portfolio
-
Table Mallinckrodt Company Details
-
Table Mallinckrodt GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mallinckrodt GCC Countries Radiopharmaceutical Main Business and Markets Served
-
Table Mallinckrodt GCC Countries Radiopharmaceutical Product Portfolio
-
Table Bracco Imaging Company Details
-
Table Bracco Imaging GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bracco Imaging GCC Countries Radiopharmaceutical Main Business and Markets Served
-
Table Bracco Imaging GCC Countries Radiopharmaceutical Product Portfolio
-
Table Triad Isotopes Company Details
-
Table Triad Isotopes GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Triad Isotopes GCC Countries Radiopharmaceutical Main Business and Markets Served
-
Table Triad Isotopes GCC Countries Radiopharmaceutical Product Portfolio
-
Table Nordion Company Details
-
Table Nordion GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nordion GCC Countries Radiopharmaceutical Main Business and Markets Served
-
Table Nordion GCC Countries Radiopharmaceutical Product Portfolio
-
Table GE Healthcare Company Details
-
Table GE Healthcare GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare GCC Countries Radiopharmaceutical Main Business and Markets Served
-
Table GE Healthcare GCC Countries Radiopharmaceutical Product Portfolio
-
Table China Isotope & Radiation Company Details
-
Table China Isotope & Radiation GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table China Isotope & Radiation GCC Countries Radiopharmaceutical Main Business and Markets Served
-
Table China Isotope & Radiation GCC Countries Radiopharmaceutical Product Portfolio
-
Table Jubilant Pharma Company Details
-
Table Jubilant Pharma GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jubilant Pharma GCC Countries Radiopharmaceutical Main Business and Markets Served
-
Table Jubilant Pharma GCC Countries Radiopharmaceutical Product Portfolio
-
Table IBA Group Company Details
-
Table IBA Group GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table IBA Group GCC Countries Radiopharmaceutical Main Business and Markets Served
-
Table IBA Group GCC Countries Radiopharmaceutical Product Portfolio
-
Table Lantheus Company Details
-
Table Lantheus GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lantheus GCC Countries Radiopharmaceutical Main Business and Markets Served
-
Table Lantheus GCC Countries Radiopharmaceutical Product Portfolio
-
Table Navidea Company Details
-
Table Navidea GCC Countries Radiopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Navidea GCC Countries Radiopharmaceutical Main Business and Markets Served
-
Table Navidea GCC Countries Radiopharmaceutical Product Portfolio
-
Figure Global Actinium-225 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lutetium-177 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radium-223 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Holmium-166 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GCC Countries Radiopharmaceutical Consumption Forecast by Country (2022-2028)
-
Table North America GCC Countries Radiopharmaceutical Consumption Forecast by Country (2022-2028)
-
Figure United States GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe GCC Countries Radiopharmaceutical Consumption Forecast by Country (2022-2028)
-
Figure Germany GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure France GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC GCC Countries Radiopharmaceutical Consumption Forecast by Country (2022-2028)
-
Figure China GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure India GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Table South America GCC Countries Radiopharmaceutical Consumption Forecast by Country (2022-2028)
-
Figure Brazil GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC GCC Countries Radiopharmaceutical Consumption Forecast by Country (2022-2028)
-
Figure Bahrain GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa GCC Countries Radiopharmaceutical Consumption Forecast by Country (2022-2028)
-
Figure Nigeria GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania GCC Countries Radiopharmaceutical Consumption Forecast by Country (2022-2028)
-
Figure Australia GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand GCC Countries Radiopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
